Tualatin, OR, United States of America

Michael Kevin Riscoe

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1989-2020

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Mind of Michael Kevin Riscoe

Introduction: Michael Kevin Riscoe, an accomplished inventor based in Tualatin, Oregon, has made significant contributions to the field of pharmaceuticals with a focus on compound derivatives that aim to combat malaria. With a total of 14 patents, Riscoe's innovations are paving the way for more effective treatments and prevention strategies.

Latest Patents: Among Riscoe's notable patents are the Quinolone-3-diarylethers, which disclose derivative compounds of ELQ-300 that incorporate an ester at position 4. These innovative compounds possess enhanced properties compared to their predecessor, ELQ-300. Furthermore, the patents detail pharmaceutical compositions formulated from these compounds and outline methods for treating and preventing malaria infections by administering these compositions to affected individuals.

Career Highlights: Riscoe has dedicated a significant part of his career to advancing healthcare solutions. He has worked with prestigious institutions such as Oregon Health & Science University and the United States Department of Veterans Affairs. His commitment to research and development in the pharmaceutical sector has led to the creation of impactful medical solutions.

Collaborations: Throughout his career, Riscoe has had the opportunity to collaborate with other esteemed professionals in the field, notably Rolf W. Winter and David J. Hinrichs. These collaborations have further enhanced the development and refinement of his innovative pharmaceutical compounds.

Conclusion: Michael Kevin Riscoe stands out as a remarkable inventor whose dedication to innovative healthcare solutions has resulted in numerous patents. His contributions to the field, especially with the Quinolone-3-diarylethers, mark significant advancements in the fight against malaria. Riscoe's work continues to inspire future innovations in pharmaceutical research and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…